| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 312.11B | 304.77B | 287.27B | 284.94B | 263.11B | 209.00B |
| Gross Profit | 97.16B | 93.55B | 85.71B | 81.35B | 80.41B | 63.36B |
| EBITDA | 48.75B | 42.91B | 45.45B | 40.84B | 39.40B | 33.53B |
| Net Income | 25.32B | 19.28B | 21.83B | 20.29B | 18.30B | 13.20B |
Balance Sheet | ||||||
| Total Assets | 470.87B | 417.78B | 441.16B | 378.46B | 370.84B | 345.76B |
| Cash, Cash Equivalents and Short-Term Investments | 120.46B | 103.53B | 121.64B | 99.62B | 109.22B | 103.17B |
| Total Debt | 37.65B | 30.68B | 48.53B | 43.23B | 58.62B | 71.86B |
| Total Liabilities | 139.29B | 124.21B | 137.44B | 120.77B | 138.70B | 143.62B |
| Stockholders Equity | 328.25B | 290.67B | 301.16B | 255.36B | 229.78B | 200.21B |
Cash Flow | ||||||
| Free Cash Flow | 19.59B | 28.07B | 18.27B | 8.65B | 15.51B | 18.45B |
| Operating Cash Flow | 34.48B | 43.71B | 40.22B | 23.62B | 27.92B | 27.41B |
| Investing Cash Flow | -9.45B | -15.60B | -21.12B | -15.65B | -10.47B | -14.99B |
| Financing Cash Flow | -29.22B | -44.88B | -6.28B | -22.95B | -19.31B | 21.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥360.83B | 5.46 | 9.34% | 4.27% | -0.48% | -35.29% | |
76 Outperform | ¥418.03B | 17.67 | 6.52% | 1.82% | 3.25% | -11.31% | |
74 Outperform | ¥302.60B | 9.05 | 5.47% | 3.41% | 2.60% | 9.50% | |
67 Neutral | ¥784.70B | 77.75 | -2.50% | 3.49% | -6.83% | -123.67% | |
65 Neutral | ¥361.21B | 10.69 | 8.14% | 2.61% | -1.45% | ― | |
65 Neutral | ¥245.40B | 6.13 | 1.47% | 4.29% | -7.45% | -71.68% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |